Oorsprong van het eerstegraads netwerk van Michael Boretti
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 23 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Michael Boretti via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| WELLS FARGO & COMPANY | Major Banks | Corporate Officer/Principal | |
ClinTrials Research, Inc.
 ClinTrials Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Marvell Technology, Inc., ClinTrials Research, Inc. engages in clinical research organization. The company is based in Cary, NC. ClinTrials Research was acquired by Indigo Acquisition Corp on April 03, 2001 for $110.42 million. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Public Communications Contact | |
| MVC CAPITAL, INC. | Investment Managers | Founder | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact Consultant / Advisor | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
HemoShear Therapeutics, Inc.
 HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Medical/Nursing Services | Chairman | |
| SQZ BIOTECHNOLOGIES COMPANY | Biotechnology | Investor Relations Contact Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree Graduate Degree | |
| Temple University (Pennsylvania) | College/University | Graduate Degree | |
| Yale University | College/University | Undergraduate Degree | |
| Towson University | College/University | Undergraduate Degree | |
| North Carolina State University | College/University | Undergraduate Degree | |
| Spring Arbor University | College/University | Director/Board Member | |
| University of Illinois | College/University | Graduate Degree | |
| University of Iowa | College/University | Doctorate Degree | |
| MESOBLAST LIMITED | Biotechnology | Chief Tech/Sci/R&D Officer | |
Khosla Ventures LLC
 Khosla Ventures LLC Investment ManagersFinance Khosla Ventures LLC (Khosla Ventures) is a venture capital firm founded in 2004 by Vinod Khosla. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Sanofi Ventures
 Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
Credit Suisse Financial Services (Israel) Ltd.
 Credit Suisse Financial Services (Israel) Ltd. Financial ConglomeratesFinance Credit Suisse Financial Services (Israel) Ltd. provides investment products and services. The company acts as a gateway to Credit Suisse's private banking, investment banking, and asset management businesses. It offers products and services including equities, bonds, mutual funds, structured products, and alternative investments. Credit Suisse Financial Services (Israel) was founded in 2007 and is headquartered in Tel Aviv, Israel | Financial Conglomerates | Corporate Officer/Principal | |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| University of North Carolina System | College/University | Undergraduate Degree | |
| Jewish Big Brothers Big Sisters of Greater Boston | Director/Board Member | ||
| Harvard Business School | College/University | Masters Business Admin | |
| Wallace E Carroll School of Management | College/University | Undergraduate Degree | |
| Solomon Schechter Day School of Greater Boston | Director/Board Member | ||
| J.F. Kapnek Trust | Director/Board Member | ||
Tri-Institutional Therapeutics Discovery Institute, Inc.
 Tri-Institutional Therapeutics Discovery Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Memorial Sloan Kettering Cancer Center, Tri-Institutional Therapeutics Discovery Institute, Inc. is an American New York-based company that encourages the Tri-Institutional community to advance their biological discoveries to preclinical studies. The company provides technical support for academic projects and offers a menu of services to translate research discoveries from bench to bedside. Tri-Institutional Therapeutics Discovery Institute achieves its mission by leveraging the infrastructure, staff, and intellectual capital of its academic and industry partners, as well as the generous support of philanthropists. The company was founded by David A. Scheinberg. | Miscellaneous Commercial Services | Consultant / Advisor | |
| PURETECH HEALTH PLC | Biotechnology | Investor Relations Contact | |
Turnstone Biologics, Inc.
 Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| IQVIA HOLDINGS INC. | Services to the Health Industry | Corporate Officer/Principal | |
| IKENA ONCOLOGY, INC. | Biotechnology | Investor Relations Contact | |
| IN8BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| TURNSTONE BIOLOGICS CORP. | Biotechnology | Director/Board Member | |
| ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
Rubedo Life Sciences, Inc.
 Rubedo Life Sciences, Inc. Packaged SoftwareTechnology Services Rubedo Life Sciences, Inc. develops intelligent drug platform to design unique, targeted and controlled therapies for age-related diseases. The company was founded by Marco Quarta, Mark Gallop and Julian Klein in 2018 and is headquartered in Silicon Valley, CA. | Packaged Software | Director/Board Member | |
Faeth Therapeutics, Inc.
 Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Faeth Therapeutics, Inc. is a clinical-stage biotechnology company based in TX. The American company focuses on developing precision therapies for metabolic oncology using a machine-learning platform and a metabolic regimen involving the patient's diet. Faeth's lead program combines FTH-001 and FTH-003 with an insulin suppressing regimen to slow tumor growth by shutting down the PI3K/MTOR pathway. The company's scientific founders include Drs. Lew Cantley, Sid Mukherjee, and Karen Vousden. Anand Parikh has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture. | Miscellaneous Commercial Services | Consultant / Advisor | |
| AKILI, INC. | Medical Specialties | Public Communications Contact |
Statistieken
Internationaal
| Verenigde Staten | 45 |
| Israël | 3 |
| Verenigd Koninkrijk | 2 |
| Frankrijk | 2 |
| Australië | 2 |
Sectoraal
| Health Technology | 23 |
| Consumer Services | 13 |
| Finance | 8 |
| Commercial Services | 4 |
| Health Services | 3 |
Operationeel
| Corporate Officer/Principal | 42 |
| Director/Board Member | 42 |
| Undergraduate Degree | 20 |
| Independent Dir/Board Member | 17 |
| Public Communications Contact | 12 |
Sterkste connecties
| Insiders | |
|---|---|
| Kevin Conroy | 22 |
| Robert Copeland | 15 |
| Robert Gould | 12 |
| John Bishop | 10 |
| John F. Weidenbruch | 9 |
| Shefali Agarwal | 9 |
| Susan Graf | 9 |
| Andrew Singer | 9 |
| Matthew Ros | 9 |
| Jason Fredette | 9 |
| Suzanne Fleming | 9 |
| Tai Ching Ho | 9 |
| Rebecca Cohen | 7 |
| Melissa Beelen | 7 |
| Joseph Beaulieu | 6 |
- Beurs
- Insiders
- Michael Boretti
- Bedrijfsconnecties
